Physician profile
Daniel Sanchez
NPI 1992007868
$7,230.64
in general payments reported to CMS, 2019-2025
30 companies · $1,820 in 2025
The $1,820 reported for 2025 was more than what 90% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,012 · 2022: $959 · 2023: $1,621 · 2024: $1,819 · 2025: $1,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,259.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,057.64 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $961.77 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $901.86 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $726.37 | 2021-2024 | |
| Pfizer INC. | $693.03 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $517.34 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $302.65 | 2021-2025 | Repatha, Otezla, Otezla |
| Daiichi Sankyo INC. | $242.72 | 2021-2025 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $221.41 | 2021-2025 | Trintellix |
| Exact Sciences Corporation | $189.99 | 2023-2025 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $183.49 | 2024-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $180.07 | 2022-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $141.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $139.42 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $117.23 | 2025 | Caplyta |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.88 | 2022-2025 | Xifaxan |
| Abbott Laboratories | $81.04 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Upsher-Smith Laboratories LLC | $72.54 | 2021 | |
| Novartis Pharmaceuticals Corporation | $67.50 | 2022-2024 | |
| Kowa Pharmaceuticals America, INC. | $60.22 | 2023-2025 | Zoryve, Livalo, Seglentis |
| Biohaven Pharmaceutical Holding Company LTD. | $49.54 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $40.57 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $37.93 | 2023-2024 | Eliquis |
| Biohaven Pharmaceuticals, INC. | $30.52 | 2021 | |
| Grifols USA, LLC | $24.43 | 2022 | |
| Inari Medical, INC. | $21.35 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astellas Pharma US INC | $21.10 | 2022 | |
| Xeris Pharmaceuticals, INC. | $19.46 | 2024 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.50 | 2021 | |
| Cequr Corporation | $13.00 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.